- Home
- TOPP vs ELEV Comparison
TOPP vs ELEV Comparison
Compare TOPP & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- ELEV
- Stock Information
- Founded
- TOPP 2014
- ELEV 2019
- Country
- TOPP United States
- ELEV United States
- Employees
- TOPP N/A
- ELEV N/A
- Industry
- TOPP
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- TOPP
- ELEV Health Care
- Exchange
- TOPP NYSE
- ELEV Nasdaq
- Market Cap
- TOPP 23.1M
- ELEV 20.0M
- IPO Year
- TOPP 2025
- ELEV 2021
- Fundamental
- Price
- TOPP $1.72
- ELEV $0.34
- Analyst Decision
- TOPP
- ELEV Buy
- Analyst Count
- TOPP 0
- ELEV 6
- Target Price
- TOPP N/A
- ELEV $2.94
- AVG Volume (30 Days)
- TOPP 155.3K
- ELEV 975.2K
- Earning Date
- TOPP 01-01-0001
- ELEV 05-23-2025
- Dividend Yield
- TOPP N/A
- ELEV N/A
- EPS Growth
- TOPP N/A
- ELEV N/A
- EPS
- TOPP 0.01
- ELEV N/A
- Revenue
- TOPP $16,039,513.00
- ELEV N/A
- Revenue This Year
- TOPP N/A
- ELEV N/A
- Revenue Next Year
- TOPP N/A
- ELEV N/A
- P/E Ratio
- TOPP $144.11
- ELEV N/A
- Revenue Growth
- TOPP N/A
- ELEV N/A
- 52 Week Low
- TOPP $0.97
- ELEV $0.22
- 52 Week High
- TOPP $4.50
- ELEV $4.33
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- ELEV 48.18
- Support Level
- TOPP N/A
- ELEV $0.33
- Resistance Level
- TOPP N/A
- ELEV $0.37
- Average True Range (ATR)
- TOPP 0.00
- ELEV 0.03
- MACD
- TOPP 0.00
- ELEV 0.00
- Stochastic Oscillator
- TOPP 0.00
- ELEV 25.54
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.